LF/HF ratio in ME/CFS

LF/HF ratio, also described as Sympathovagal balance, belongs to the autonomic group of ME/CFS (ME/CFS, CFS) markers, but reports against healthy controls point in different directions. Symptom domains tied to this marker in the source include autonomic imbalance. This entry summarises Nelson et al. 2019. Group-level associations like this do not translate into an individual diagnostic cut-off.

↕ InconsistentAutonomic

Summary

Direction in ME/CFS↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryAutonomic
Also described asSympathovagal balance
Compared againstHC (healthy controls)
Associated symptomsAutonomic imbalance
Test typeClinical or physiological test
SourceNelson et al. 2019 — doi:10.1186/s12967-019-02100-4
Condition atlasME/CFS Biomarker Atlas

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term The change in LF/HF-ratio (a measure of autonomic control) during head-up tilt-test (4 registered trials use a matching outcome measure).

Clinical trials using LF/HF ratio as an outcome

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Related Autonomic markers in ME/CFS

Full list: ME/CFS Biomarker Atlas.

Frequently asked questions

Is LF/HF ratio high or low in ME/CFS?

Mixed. Some studies report higher and others lower LF/HF ratio in ME/CFS compared with healthy controls, so no single direction is established. Source: Nelson et al. 2019.

What symptoms is LF/HF ratio associated with in ME/CFS?

The cited literature associates this marker with Autonomic imbalance. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures LF/HF ratio?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal LF/HF ratio result diagnostic of ME/CFS?

No. No single biomarker is diagnostic of ME/CFS. LF/HF ratio findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). LF/HF ratio in ME/CFS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/me-cfs/lf-hf-ratio.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from me-cfs.json · Browse: ME/CFS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.